Transcript B2B Pop Health, April 7_2009

Back to Basics, 2009
POPULATION HEALTH (2):
CLINICAL PRESENTATIONS
N Birkett, MD
Epidemiology & Community Medicine
Based on slides prepared by Dr. R. Spasoff
April 7, 2009
1
THE PLAN(2)
• First class
– mainly lectures
• Other classes
– About 1.5-2 hours of lectures
– Review MCQs for 60 minutes
• A 10 minute break about half-way through
• You can interrupt for questions, etc. if
things aren’t clear.
April 7, 2009
2
THE PLAN (4)
• Session 2 (April 7)
– Clinical Presentations
• Periodic Health Examination
– You will get a full day on this topic later in the course
– Focus here is on key conditions, risks and general issues
•
•
•
•
•
•
April 7, 2009
Immunization
Occupational Health
Health of Special Populations
Disease Prevention
Determinants of Health
Environmental health
3
78.3 PERIODIC HEALTH
EXAMINATION (1)
• “Determine patient’s risks for common gender/age specific
conditions”
• This would involve knowing something about prevalence
of condition, as well as patient’s risk factors for it.
• Objectives identify certain common conditions for each
age group
• Use periodic health exam for health promotion/disease
prevention interventions.
• Case-finding and screening for disease & risky behaviours
April 7, 2009
4
Examples from prior MCC (1)
• Infant/Toddler <3 years
– Delayed growth & development
– Abuse/neglect
• Child 3-12 years
–
–
–
–
Vision/hearing defect
“Accidents”
Delayed development
Abuse/neglect
April 7, 2009
5
Examples from prior MCC (2)
• Youth 13-24 years
–
–
–
–
–
–
–
MVA
Substance abuse
STDs
Contraception
Sedentary lifestyle
Female: rubella/HPV immunization
Eating disorders (don’t know why not included)
April 7, 2009
6
Examples from prior MCC (3)
• Adult 25-44 years
–
–
–
–
–
–
Substance abuse
Eating disorders
Family violence
Hypertension
Female: cervical cancer
Male: elevated cholesterol, MVA
April 7, 2009
7
Examples from prior MCC (4)
• Middle age 45-64 years
– Lung cancer
– Colon cancer
• Method of screening is controversial
• Screening colonoscopy has serious potential risks and low
patient acceptance but can treat adenomas
– Skin cancer
– Female: osteoporosis, breast cancer
– Male: IHD, prostate cancer (55 and up)
• Role of PSA screening is controversial
April 7, 2009
8
Examples from prior MCC (5)
• Seniors >64 yrs
–
–
–
–
–
–
Elder abuse
Falls
Drug-related morbidity
Nutrition
Cancer
Dementia
April 7, 2009
9
78.3 PERIODIC HEALTH
EXAMINATION (2)
• “Elicit information about ethnic, family,
socio-economic, occupational, and
lifestyle characteristics that are known
to be convey a high risk for a particular
condition.”
• Previous MCC objectives provided a list
for each age group
April 7, 2009
10
Risk factors from MCC (1)
• Infant, Toddler, Child:
–
–
–
–
Risk factors at conception, pregnancy, birth
Familial factors
Existing signs of illness
Environment (missed immunization, diet,
passive smoke inhalation, skin protection)
– Height, weight, head circumference, medical
status, developmental milestones
April 7, 2009
11
Risk factors from MCC (2)
• Youth
–
–
–
–
–
–
Nutrition
Physical activity
Drug use
Sexual/social/peer activities
Emotional concerns
Communication with parents
April 7, 2009
12
Risk factors from MCC (3)
• Adults:
–
–
–
–
Lifestyle patterns
Psychological, social and physical functioning
Symptoms of any illness
Situational factors affecting mood
April 7, 2009
13
Risk factors from MCC (4)
• Seniors:
–
–
–
–
–
–
–
Past illness
Lifestyle factors
Mental function
Drug use
Physical and social activity
Emotional concerns
Social relations and support systems
April 7, 2009
14
Risk factors from MCC (5)
• General:
– Use lab tests only for specific to age and sex
concerns. Do not use the same battery of tests
in all patients.
– Interpret results taking into account age/gender,
etc.
April 7, 2009
15
78.3 PERIODIC HEALTH
EXAMINATION (3)
• “Conduct an effective plan of management”
• All patients:
– Encourage patient control over health
– Follow recommendations of CTFPHC
(http://www.ctfphc.org/ )
• Patient with risk factors:
– Counsel about risk factor reduction, using
health belief model, stages of change model,
etc.
April 7, 2009
16
78.3 NEWBORN
ASSESSMENT/NUTRTION
• Developmental surveillance
– Anticipatory guidance to new parents
• Nutritional issues
– Importance of breast-feeding
– Bottle feeding; solid foods
• Well-newborn care
– Bathing, skin care
April 7, 2009
17
78.3 INFANT & CHILD
IMMUNIZATION (1)
• “Discuss the population health benefits of immunization
programs”
• Probability of contracting communicable disease depends
on probability that contacts have the disease, or are carriers
• If sufficient proportion of population is immune, then
disease will not spread (herd immunity)
• Prevention is usually cheaper and more effective than
treatment (if treatment even exists)
• Possibility of eradicating some diseases
• Implications for school attendance (Ontario)
– Mandatory choice vs.. mandatory immunization
– Exclusion from school for non-immunized children
April 7, 2009
18
Standard immunizations(2007)
Age 0-16
•
•
•
•
•
•
•
Diphtheria
Tetanus
Pertussis
Polio
H. influenzae
Mumps
Measles
April 7, 2009
• Rubella
• Hepatitis B
• Chickenpox
(varicella)
• Pneumococcus C
• Meningococcus C
• Influenza
• HPV (girls only)
Taken from: Canadian Immunization Guide, 2006
19
April 7, 2009
20
IMMUNIZATION: HPV
• Protects against 4 strains of HPV
– Type 16/18 (linked to 70% of cervical cancer)
– Type 6/11 (linked to 90% of anogenital warts)
• Approved for use in women aged 9-26.
• Need three doses (0, 2 and 6 months)
• 1st dose prior to initial sexual contact
– Age 9-13
• Ontario
– Offered free on voluntary basis to all Grade 8 girls
• Why not offered to men (and why it should be)?
–
–
–
–
No RCT’s in men (drug companies)
Rectal cancer
Genital warts
STD & shared responsibility for interrupting transmission
April 7, 2009
21
78.3 INFANT & CHILD
IMMUNIZATION (2)
• “State that a lapse in immunization
schedule does not require re-instituting the
initial series, merely giving it at the next
visit”
• Done!
April 7, 2009
22
78.3 INFANT & CHILD
IMMUNIZATION (3)
• “Communicate to patients and parents about vaccine
benefits and risks”
• Obtain an immunization history on all children
• Late immunization is still very effective
• Immigrants require special attention
– Depends on availability of good records
– Countries have different immunization coverage
– Were the previous vaccines ‘potent’?
• Travel
– Update regular vaccinations
– Follow legal requirements
• Yellow fever
April 7, 2009
23
Immunization risks
• Outcomes NOT related to vaccines
– SIDS (diptheria, tetanus, whole cell pertussis, multiple
immunizations)
– MS (Hep B, influenza)
– Type 1 diabetes (multiple)
– Autism (MMR)
– Infections (H. influenza, multiple)
– Encephalopathy (diptheria, tetanus)
– Spasms (diptheria, tetanus)
April 7, 2009
24
78.3 INFANT & CHILD
IMMUNIZATION (3)
• “Discuss misconceptions about immunization
contraindications”
• Following are not contraindications:
–
–
–
–
–
–
–
–
Mild/moderate local reactions to previous dose
Mild acute illness with or without fever
Taking antibiotics
Allergy to penicillin, duck, molds, pollens, eggs
Positive Mantoux TB skin test
Breast feeding
Asplenia
Prior febrile seizure reaction (consider prophylactic
acetaminophen)
April 7, 2009
25
78.3 INFANT & CHILD
IMMUNIZATION (3A)
• Valid contraindications are:
– Prior anaphylactic reaction to component of vaccine
– Significant immunosuppression (live vaccines only)
– Pregnancy (live vaccines only)
• Take special caution for:
– Chronic illness/immunocompromised state
• May reduce response
– Hx of Guillain-Barré syndrome in last 8 weeks
– Recent IGG or blood product use (live vaccines)
• May reduce response
– Severe bleeding disorder
April 7, 2009
26
78.3 INFANT & CHILD
IMMUNIZATION (4)
• “List possible complications of immunization”
• Seizures (secondary to fever)
• Anaphylaxis
• Neurological damage (rarely, if ever)
– Most evidence is due to diagnostic correlations, not
causation
– Use acellular pertussis
April 7, 2009
27
78.3 INFANT & CHILD
IMMUNIZATION (5)
• “Discuss immunization of immuno-compromised children
(e.g., asplenia, chronic diseases or seizures)”
• Avoid live (attenuated) vaccines; use killed vaccines
• Splenectomy (surgical or congenital/functional)
– Not a contra-indication to vaccination
• Immuno-suppression
– Avoid live vaccines
– Follow regular immunization schedule
– High dose steroids can mute immune response
• Congenital immunodeficiency
– Read the Guide!
April 7, 2009
28
Communicable disease control
Time scale
Exposure
Incubation period
(personal surveill.)
Clinical onset
Period of infectivity
(isolation)
“Cure”
time
April 7, 2009
29
Communicable disease control
Approaches
• Enhance host resistance
– Active or passive immunization
• Interrupt transmission
– Isolate cases until no longer infectious
– Contact tracing; observe until incubation period
is over
– Individual measures (hygiene, barriers)
April 7, 2009
30
78.3 WORK-RELATED
HEALTH ISSUES
• “Elicit history of patient’s occupation and possible
exposure and identify potential relationship to patient
presentation
• “Counsel patients about safety issues and report findings
to affected patients as well as employers (considering
medical confidentiality issues)”
• Consider underlying medical conditions and work risk
• Importance in Canada
– 920 work place deaths in 2001
– 373,216 lost time injuries in 2001
Well covered in UTMCCQE, except 2 topics
April 7, 2009
31
Work-related Health Issues (2)
• Under provincial jurisdiction except for 16 federal
regulated industries (e.g. banks, airports, highway
transport).
– 90% of workers are under provincial jurisdiction
• Ontario: Occupational Health and Safety Act
– Defines rights of workers: participate, know, refuse and stop.
• Ontario: Workplace Safety and Insurance Act
–
–
–
–
Establishes WSIB to oversee work-site injuries/disease
Funded by employers
Non-fault protection but no right to sue
MD must submit medical report to WSIB; no need for patient
waiver.
– MD must report exposure to designated substances
• Asbestos, arsenic, benzene, lead, mercury, vinyl chloride, etc.
April 7, 2009
32
Essential responsibilities of an
Occupational Health Program
•
•
•
•
•
Health evaluation of employees
Diagnosis/treatment of occup injuries or illnesses
Emergency treatment of other injury or illness
Education of employees re: occupational hazards
Evaluation of programs for the use of indicated
personal protective devices
• Assist management in providing a safe and
healthful work environment. Inspect workplace.
April 7, 2009
33
WHMIS
Workplace Hazardous Materials
Information System
• Informs workers of hazards that they face
• Labels
• MSDS (Materials Safety Data Sheets)
• Worker education
April 7, 2009
34
Work-related Health Issues (3)
• Categories of occupational hazards
– Chemical
• Dusts, heavy metals, gasses, second-hand smoke
– Physical
• Noise, temperature, air pressure, radiation
– Biological
– Mechanical
• Repetitive strain, trauma
– Psychosocial stress
April 7, 2009
35
Work-related Health Issues (4)
• Work place safety issues can affect family
members as well as the workers.
• Asbestos
– Causes asbestosis and lung cancer in miners
and other workers.
– Asbestos in the air adheres to work clothing,
even if the clothes are brushed
– Cleaning of clothes at home liberates asbestos
fibers and has been shown to cause cancer in
family members.
April 7, 2009
36
78.7 HEALTH OF SPECIAL
POPULATIONS (1)
• Focus is on the impact of inequities in the
determinants of health in population groups.
• Affects risk, access to health care services and
treatment options.
• Need to consider cultural issues
• MCC lists five special populations
–
–
–
–
–
First Nations, Inuit and Métis
Global health & immigration
Persons with disabilities
Homeless persons
Extremes of the age continuum
April 7, 2009
37
78.7 HEALTH OF SPECIAL
POPULATIONS (2)
• These are not the only groups which matter,
nor the most important groups
–
–
–
–
Children in poverty
Women in abusive relationships
People with addictions
End of life care
• Decision of what groups to list is a political
decision, not a medical or educational one
• Treat these groups as ‘examples’ and apply
the principles to other groups.
April 7, 2009
38
Special populations (1)
• First Nations, Inuit and Métis peoples
– General issues to consider
• Cultural diversity
• Governance and related issues (land claims)
and impact on social structure, and health
• Role of social and spiritual determinants and
health
• Types of health care services
– Impact of remote location
– Reservations vs. non-reservation issues
April 7, 2009
39
Special populations (2)
• First Nations, Inuit and Métis peoples
– Trauma/poisoning/SIDS/ALTE (Apparent Life
Threatening Event Syndrome)
• also suicide, substance use
–
–
–
–
Circulatory diseases (incl rheumatic fever)
Neoplasms
Respiratory diseases
Infection (gastroenteritis, otitis media, infectious
hepatitis)
– Diabetes
April 7, 2009
40
Special populations (3)
• Global Health and Immigrations:
– Importance of travel histories
– Food safety, product safety in the era of
globalization
– Cultural perspectives of immigrants
– Barriers to health care access and use of
preventive services in immigrants
April 7, 2009
41
Special populations (4)
• People with disabilities
– Special challenges in accessing health and
social services
– Stigma and social challenges
– Access to public buildings, etc.
– Unique social and health services available
• Need to become aware of local options
– Institutional care vs. community care
April 7, 2009
42
Special populations (5)
• Homeless people
– Health risks of being homeless
• Shelter and food
• Hygiene
– Health risk associated with reason for being
homeless
• Mental health
• Addictions
– Access to social and health services
April 7, 2009
43
Special populations (6)
• Children in poverty
– Low birth weight
– trauma/poisoning
– Mouth problems (abnormalities in teeth and
jaws)
– Fever/infectious diseases
– Psychiatric problems
April 7, 2009
44
Special populations (7)
• Seniors:
– Musculoskeletal
• includes falls & injuries
–
–
–
–
–
Hypertension/heart diseases
Respiratory diseases
Dementia
Polypharmacy
Social isolation
April 7, 2009
45
Two priests, a Dominican and a Jesuit met
for their regular Monday morning walk.
They got into a discussion about whether it
was a sin to smoke and pray at the same
time. The Jesuit was sure that it wasn’t a sin
while the Dominican was sure that it was.
Unable to resolve it, they decided to ask their
superiors.
April 7, 2009
46
The next week, they met again.
Dominican: What did your
superior say?
Jesuit:
He said that it
definitely was not a sin.
Dominican: That’s strange because mine
said that it was a sin.
Jesuit:
What did you ask him?
Dominican: Whether it was a sin to smoke
while praying.
Jesuit:
I asked if it was a sin to pray
while smoking.
April 7, 2009
47
78.3 POPULATION (1)
Disease Prevention
• “Discuss the 3 levels of disease
prevention and strategies for health
promotion (e.g., education,
communication/behaviour change,
social marketing, healthy public policy,
community development and
organization, community-wide
prevention, and diffusion of innovation)”
April 7, 2009
48
Levels of Prevention
• Categories are not black and white.
• Primary prevention:
– Strategies applied BEFORE disease starts.
– E.g. Immunization
• Secondary prevention:
– Early identification of disease
– Screening; thrombolytic therapy of MI
– Some people suggest secondary prevention relates to reducing the
severity of disease.
• Tertiary prevention:
– Treatment and rehabilitation of disease
April 7, 2009
49
Screening
• Can either:
– Detect pre-disease states (e.g. dysplasia)
– Detect the disease at an early stage
• Criteria for when screening is useful
– Disease related
• Significant cause of ‘illness’
• Early detection can alter the course of the disease
– Test related
• High sensitivity (and specificity if possible)
• Safe, rapid, cheap, acceptable
– Healthcare System related
• Adequate capacity for follow-up/treatment
April 7, 2009
50
Strategies for Prevention (1)
High Risk Approach
• Identify individuals at high risk and attempt
to reduce their risk
• Requires testing entire population (costs,
false positives)
• Asks targeted people to act differently from
their peers
• Misses most cases (which occur in lower
risk people)
April 7, 2009
51
Strategies for Prevention (2)
High Risk Approach
April 7, 2009
52
Strategies for Prevention (3)
Population Approach
• Attempts to shift distribution of risk factor
in whole population
• Gets to root of the problem
• Shades into health promotion
• Benefits everyone
April 7, 2009
53
Strategies for Prevention (4)
Population Approach
April 7, 2009
54
78.1 POPULATION (2)
Determinants of Health
• “Explain that factors such as geographic
location, gender, and ethnic origin influence
some of the determinants of health, but
health status is in turn influenced by
differential allocation and distribution of
some of the determinants of health”
See below…
April 7, 2009
55
Determinants of Health
(Useful list from MCC Objectives)
•
•
•
•
•
•
•
•
•
•
•
•
Income/social status
Social support networks
Education/literacy
Employment/working conditions
Social environments
Physical environments
Personal health practices/coping skills
Healthy child development
Biology/genetic endowment
Health services
Gender
Culture
April 7, 2009
56
Differential distribution of
determinants of health
• Poverty is associated with increased
occurrence of nearly all health problems,
often working through known
determinants/risk factors, e.g.., smoking
• Income inequality appears to be associated
with worse overall health in the population,
perhaps through decreased social cohesion,
community investment, etc.
April 7, 2009
57
78.3 POPULATION (3)
Health Promotion
• “Select (identify) population health
issues better managed by means of
health promotion rather than traditional
medical interventions”
• Physical or social environmental
hazards, (e.g., pollution, poverty)
• Environmental interventions are usually
more effective than behavioural ones
April 7, 2009
58
78.6 ENVIRONMENT (1)
• “Describe clinical presentations caused or
aggravated by environmental exposures that
are virtually indistinguishable from ones
caused by other conditions (e.g., headache
from CO poisoning is similar to tension
headache or migraine; asthma)”
• Done. You have to identify them from the history.
April 7, 2009
59
78.6 ENVIRONMENT (2)
• “In patients whose immediate (e.g. allergic
reaction), subacute (e.g. asthma) or delayed
(e.g. pneumoconiosis) presentation may be
linked to environmental exposure, elicit and
environmental history and identify a/the
potential source of the problem”
• Need to know when presentation may link to
environmental agent.
• Consider list of candidate agents (later)
April 7, 2009
60
78.6 ENVIRONMENT (3)
Four areas to focus on for environmental history
1. Determine whether symptoms are worse:
–
–
–
–
at home,
at work
at leisure activities
on weekends or week days
–
And what is relationship to recent or past
exposures (e.g. fumes, dusts, chemicals, radiation,
etc.)
April 7, 2009
61
78.6 ENVIRONMENT (4)
2. Determine whether an illness is occurring
in an unexpected person (e.g. lung cancer
in a non-smoker) or whether symptoms
developed without a clear etiology
3. Determine presence of nearby industrial
plants, commercial businesses or dump
sites.
– ‘nearby’ needs to consider hydrology,
weather patterns, etc.
April 7, 2009
62
78.6 ENVIRONMENT (5)
4. Obtain information about:
–
–
–
–
–
–
–
–
–
April 7, 2009
Home insulation (UFI),
Home heating and cooling systems
Cleaning agents used
Pesticide use
Water supply and leaks
Recent renovations
Air pollution
Hobbies
Hazardous waste contamination, spills, etc.
63
78.6 ENVIRONMENT (6)
• “Interpret critical clinical and laboratory
findings which were key in the
processes of exclusion, differentiation
and diagnosis.
• Doesn’t really say a whole lot.
• Main point is to learn where to get
information and help in dealing with
environmental issues (next 2 slides)
April 7, 2009
64
78.6 ENVIRONMENT (7)
• “Select and consult labels or Material Safety
Data Sheets (MSDS), poison control centers,
consultants, agencies, and other references
for information.”
• Sources of help: Ministry of Labour, occupational
health clinics (not many freestanding ones)
• MSDS are available on the web. Find one you
like and book-mark it for use in your practice.
April 7, 2009
65
78.6 ENVIRONMENT (8)
• “Select consultants (environmental
medicine specialists, toxicologists,
governmental agencies, industrial
hygienists, etc.) for the purpose of
documenting and quantifying exposure.”
• Industrial (occupational) hygienists: usually
chemical engineers with post-graduate
training in measurement and control of
environmental hazards
April 7, 2009
66
78.6 ENVIRONMENT (9)
• “Select laboratory tests for the patient
to establish exposure or select
investigations to establish the presence
of adverse health effects in target
organs:
– Blood lead levels to access exposure
– Serum creatinine to look for effect on kidney
function.
April 7, 2009
67
78.6 ENVIRONMENT (10)
• “If evidence supports, or a strong suspicion
exists for, a causal connection between
exposure and the clinical presentation, notify
the appropriate authorities to inspect the site
and thereafter to decrease and eliminate
exposure.
• Your responsibility lies beyond the specific
patient.
• Who do you contact? Next slide 
April 7, 2009
68
ENVIRONMENT (11)
• Environmental Health Jurisdiction
– Public Health Unit
• Sanitation, reportable diseases, local hazard assess
– Municipal
• Garbage disposal, recycling
– Province/territory
• Toxic waste disposal, air/water standards
– Federal
• Food regulations, designating toxic substances
– International
• Treaties like Kyoto
April 7, 2009
69
ENVIRONMENT (12)
• Risk assessment/management
• Epidemiology vs.. toxicology
– Air
• Includes climate change
– Water
• Biological & chemical risks
– Soil
– Food
• Biological & chemical risks
April 7, 2009
70
ENVIRONMENT (13)
• AIR
–
–
–
–
–
–
–
–
–
Particulates
Ground-level ozone
Carbon monoxide
Sulphur dioxide, nitrogen dioxide
Biological agents (e.g. moulds, mites)
Organic compounds (e.g. benzene)
Heavy metals
Radiation
Global warming
April 7, 2009
71
ENVIRONMENT (14)
• WATER
– Biological agents
• Mainly animal and human waste
• Very high risk in aboriginal Canadians
– Chemical agents
• Organic compounds
• Chlorination byproducts.
• SOIL
– Lead, pesticides, industrial waste
– Infants/toddlers are at highest risk
April 7, 2009
72
ENVIRONMENT (15)
• FOOD
– Biological Contaminants
•
•
•
•
•
•
•
•
Salmonella
Campylobacter
E. Coli
Listeria monocytogenes
Clostridium botulinum
BSE
Avian flu
Viruses, mould, parasites
– Chemical Contaminants
• PCBs, dioxins/furans, pesticide residues (e.g. DDT), endocrine
disruptors, food additives
• antibiotics
April 7, 2009
73